Methods for providing therapeutic agents to treat damaged spiral ganglion neurons

Lynne M. Bianchi, Yael Raz

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Sensorineural hearing loss, characterized by damage to sensory hair cells and/or associated nerve (fibers is a leading cause of hearing disorders throughout the world. To date, treatment options are limited and there is no cure for damaged inner ear cells. Because the inner ear is a tiny organ housed in bone deep within the skull, access to the inner ear is limited, making delivery of therapeutic agents difficult. In recent years scientists have investigated a number of growth factors that have the potential to regulate survival or recovery of auditory neurons. Coinciding with the focus on molecules that may restore function are efforts to develop novel delivery methods. Researchers have been investigating the use of mini osmotic pumps, viral vectors and stem cells as a means of providing direct application of growth factors to the inner ear. This review summarizes recent findings regarding the molecules that may be useful for restoring damaged spiral ganglion neurons, as well as the advantages and disadvantages of various delivery system.

Original languageEnglish (US)
Pages (from-to)195-199
Number of pages5
JournalCurrent Drug Targets: CNS and Neurological Disorders
Volume3
Issue number3
DOIs
StatePublished - Jun 2004
Externally publishedYes

Fingerprint

Spiral Ganglion
Inner Ear
Neurons
Intercellular Signaling Peptides and Proteins
Hearing Disorders
Sensorineural Hearing Loss
Therapeutics
Nerve Fibers
Skull
Stem Cells
Research Personnel
Bone and Bones

Keywords

  • Cochlea
  • Growth factor
  • Hearing loss
  • Spiral ganglion
  • Stem cell
  • Viral vector

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

Methods for providing therapeutic agents to treat damaged spiral ganglion neurons. / Bianchi, Lynne M.; Raz, Yael.

In: Current Drug Targets: CNS and Neurological Disorders, Vol. 3, No. 3, 06.2004, p. 195-199.

Research output: Contribution to journalReview article

@article{40edac4eb72c46f38b8692e1b84c535a,
title = "Methods for providing therapeutic agents to treat damaged spiral ganglion neurons",
abstract = "Sensorineural hearing loss, characterized by damage to sensory hair cells and/or associated nerve (fibers is a leading cause of hearing disorders throughout the world. To date, treatment options are limited and there is no cure for damaged inner ear cells. Because the inner ear is a tiny organ housed in bone deep within the skull, access to the inner ear is limited, making delivery of therapeutic agents difficult. In recent years scientists have investigated a number of growth factors that have the potential to regulate survival or recovery of auditory neurons. Coinciding with the focus on molecules that may restore function are efforts to develop novel delivery methods. Researchers have been investigating the use of mini osmotic pumps, viral vectors and stem cells as a means of providing direct application of growth factors to the inner ear. This review summarizes recent findings regarding the molecules that may be useful for restoring damaged spiral ganglion neurons, as well as the advantages and disadvantages of various delivery system.",
keywords = "Cochlea, Growth factor, Hearing loss, Spiral ganglion, Stem cell, Viral vector",
author = "Bianchi, {Lynne M.} and Yael Raz",
year = "2004",
month = "6",
doi = "10.2174/1568007043337454",
language = "English (US)",
volume = "3",
pages = "195--199",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Methods for providing therapeutic agents to treat damaged spiral ganglion neurons

AU - Bianchi, Lynne M.

AU - Raz, Yael

PY - 2004/6

Y1 - 2004/6

N2 - Sensorineural hearing loss, characterized by damage to sensory hair cells and/or associated nerve (fibers is a leading cause of hearing disorders throughout the world. To date, treatment options are limited and there is no cure for damaged inner ear cells. Because the inner ear is a tiny organ housed in bone deep within the skull, access to the inner ear is limited, making delivery of therapeutic agents difficult. In recent years scientists have investigated a number of growth factors that have the potential to regulate survival or recovery of auditory neurons. Coinciding with the focus on molecules that may restore function are efforts to develop novel delivery methods. Researchers have been investigating the use of mini osmotic pumps, viral vectors and stem cells as a means of providing direct application of growth factors to the inner ear. This review summarizes recent findings regarding the molecules that may be useful for restoring damaged spiral ganglion neurons, as well as the advantages and disadvantages of various delivery system.

AB - Sensorineural hearing loss, characterized by damage to sensory hair cells and/or associated nerve (fibers is a leading cause of hearing disorders throughout the world. To date, treatment options are limited and there is no cure for damaged inner ear cells. Because the inner ear is a tiny organ housed in bone deep within the skull, access to the inner ear is limited, making delivery of therapeutic agents difficult. In recent years scientists have investigated a number of growth factors that have the potential to regulate survival or recovery of auditory neurons. Coinciding with the focus on molecules that may restore function are efforts to develop novel delivery methods. Researchers have been investigating the use of mini osmotic pumps, viral vectors and stem cells as a means of providing direct application of growth factors to the inner ear. This review summarizes recent findings regarding the molecules that may be useful for restoring damaged spiral ganglion neurons, as well as the advantages and disadvantages of various delivery system.

KW - Cochlea

KW - Growth factor

KW - Hearing loss

KW - Spiral ganglion

KW - Stem cell

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=3042724635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042724635&partnerID=8YFLogxK

U2 - 10.2174/1568007043337454

DO - 10.2174/1568007043337454

M3 - Review article

C2 - 15180480

AN - SCOPUS:3042724635

VL - 3

SP - 195

EP - 199

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 3

ER -